CorMedix's DefenCath cuts infection risk by 71% for dialysis patients. Despite its potential, CMD stock is fairly priced post ...

Greg Vigna, MD Polyurethane PICC lines are ineffective in reducing hospital-acquired infections, while super-hydrophilic lines offer better ...

CorMedix Inc.'s DefenCath reduces catheter infections by 71%, but the limited market potential challenges long-term adoption.

Oregon hospitals have reported a modest decline in health care-associated infections (HAIs) among patients in 2023, according ...

Previously, leaders set arbitrary reduction goals, such as reducing infections from 30 to 10. But frontline workers didn’t understand why or how those numbers were picked or the value of changing.

erythema or induration within 2 cm of the catheter exit site in the absence of associated bloodstream infection and without concomitant purulence Clinical sepsis Requires one of the following with ...

This study investigates the microbiological and clinical factors associated with bloodstream infection-induced SAE. Methods: We analyzed data from the MIMIC-IV database, including 16,141 sepsis ...

Hyperglycemia at the time of acquiring CCABSI is common and associated with ICU mortality in critically ill children. Strategies to monitor and control BG to prevent and/or minimize hyperglycemia ...